Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.41 -1.52 (-3.90%)
As of: Oct 2, 2026 · 1:52 PM EDT

Xenon Pharmaceuticals (XENE) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Xenon Pharmaceuticals (XENE) posted Depreciation & Amortization (CF) of $558,000 for Q2 2026, down 11.7% from $632,000 a year earlier and down 4.9% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Xenon Pharmaceuticals was $2.4 million, down 8.7% year-over-year; for FY2025, it was $2.54 million, down 0.7% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 31.6% (FY2020 to FY2025).
  • In prior years, Xenon Pharmaceuticals' Depreciation & Amortization (CF) was $2.56 million in FY2024 (+24.2%), $2.06 million in FY2023 (+46.7%), $1.41 million in FY2022 (+55.1%) and $906,000 in FY2021 (+40.7%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q4 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last five quarters, with an average decline of 12.2% over the last seven quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2023, with growth of 384.4%; the weakest was Q3 2024, with a decline of 61.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $587,000 (Q1 2026), $611,000 (Q4 2025) and $641,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn - 558,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 558,000.00
Mar 31, 2026 587,000.00
Dec 31, 2025 611,000.00
Sep 30, 2025 641,000.00
Jun 30, 2025 632,000.00
Mar 31, 2025 659,000.00
Dec 31, 2024 666,000.00
Sep 30, 2024 667,000.00
Jun 30, 2024 641,000.00
Mar 31, 2024 586,000.00
Dec 31, 2023 -629,000.00
Sep 30, 2023 1.73 Mn
Jun 30, 2023 602,000.00
Mar 31, 2023 354,000.00
Dec 31, 2022 296,000.00
Sep 30, 2022 358,000.00
Jun 30, 2022 375,000.00
Mar 31, 2022 376,000.00
Dec 31, 2021 270,000.00
Sep 30, 2021 209,000.00
API Access

Xenon Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=XENE&period=max&api_key=YOUR_API_KEY